Unchanged cellular inflammatory response following recurrent ST-elevation myocardial infarction

Joyce Lim1, James King2, Trent Williams3

  • 1Heart and Stroke Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.

PubMed

Insights

Recurrent ST-elevation myocardial infarctions (STEMIs) do not show a dampened inflammatory response. Leukocyte counts and subtypes remain similar after a second STEMI, indicating no long-term cellular memory effect.

Area of Science:

  • Cardiology
  • Immunology
  • Hematology

Background:

  • Recurrent ST-elevation myocardial infarctions (STEMIs) are linked to worse patient outcomes.
  • A blunted hematopoietic response is hypothesized as the cause, but human data is lacking.
  • Investigating leukocyte response after first vs. second STEMI is crucial.

Purpose of the Study:

  • To determine if the inflammatory response, specifically leukocyte subtypes, is altered after recurrent STEMIs.
  • To validate the hypothesis of a diminished hematopoietic response in patients with repeated myocardial infarctions.

Main Methods:

  • Retrospective cohort study design.
  • Analysis of full blood counts (leukocyte response and subtypes) within 24 hours and daily post-percutaneous coronary intervention (PCI) for first and second STEMI.
  • Comparison of qualitative and quantitative differences in leukocyte response between the two events.

Main Results:

  • Thirty-one patients with recurrent STEMI were analyzed.
  • No significant differences were found in mean or peak leukocyte response (including subtypes) between the first and second STEMI, even after adjusting for infarct size.
  • Leukocyte response remained consistent from admission to day three post-PCI.

Conclusions:

  • The cellular inflammatory response, measured by circulating leukocytes and their subtypes, does not exhibit a long-term memory effect after recurrent STEMIs.
  • The hypothesis of a dampened hematopoietic response contributing to poorer prognosis in recurrent STEMI is not supported by this study's findings on leukocyte dynamics.
Abstract